Technical Analysis for PCRX - Pacira Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 69.43 1.71% 1.17
PCRX closed up 1.71 percent on Wednesday, April 14, 2021, on 69 percent of normal volume.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical PCRX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Up Strength 0.00%
Bollinger Band Squeeze Range Contraction 1.71%
NR7 Range Contraction 1.71%
NR7-2 Range Contraction 1.71%
BB Squeeze + Lower Band Touch Range Contraction 1.71%
BB Squeeze Started Range Contraction 1.71%
Lower Bollinger Band Touch Weakness 1.71%
Older End-of-Day Signals for PCRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
Up 3% about 16 hours ago
Rose Above 20 DMA about 16 hours ago
10 DMA Support about 17 hours ago
20 DMA Resistance about 17 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pacira Pharmaceuticals, Inc. Description

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Immune System Pain Surgery Pharmaceutical Products IBD 50 Lymphoma Pharmacology Rheumatoid Arthritis Drug Delivery Dosage Forms Suspension Nerve Acute Pain Piperidines Bupivacaine Drug Delivery Technology Local Anesthetic Meningitis Methotrexate Liposome Surgical Site

Is PCRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 80.0
52 Week Low 34.5075
Average Volume 398,754
200-Day Moving Average 62.73
50-Day Moving Average 71.82
20-Day Moving Average 69.48
10-Day Moving Average 68.78
Average True Range 2.85
ADX 11.16
+DI 17.34
-DI 14.39
Chandelier Exit (Long, 3 ATRs ) 66.20
Chandelier Exit (Short, 3 ATRs ) 75.15
Upper Bollinger Band 71.87
Lower Bollinger Band 67.09
Percent B (%b) 0.49
BandWidth 6.88
MACD Line -0.77
MACD Signal Line -0.74
MACD Histogram -0.0351
Fundamentals Value
Market Cap 3.02 Billion
Num Shares 43.4 Million
EPS 2.93
Price-to-Earnings (P/E) Ratio 23.69
Price-to-Sales 6.33
Price-to-Book 4.61
PEG Ratio -3.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 72.18
Resistance 3 (R3) 72.24 71.40 71.72
Resistance 2 (R2) 71.40 70.70 71.36 71.56
Resistance 1 (R1) 70.41 70.27 70.91 70.35 71.41
Pivot Point 69.57 69.57 69.81 69.53 69.57
Support 1 (S1) 68.58 68.87 69.08 68.52 67.45
Support 2 (S2) 67.74 68.44 67.70 67.30
Support 3 (S3) 66.75 67.74 67.14
Support 4 (S4) 66.69